Dr. OZ Suggests Delaying Gardasil Vaccination; CBCD Agrees
Doctor and television personality, Dr. Oz, recently appeared on HuffPost
Live, to discuss the Gardasil HPV vaccine.
If your doctor belongs to our network of doctors, you are entitled to a discount. When ordering, please tell us the name of your doctor and we will check for you.
We accept all types of credit cards (credit, debit, pre-paid, etc.). Sorry, we don't accept other modes of payment.
We can also take your order over the phone. Call us if you would like to use this option.
To keep your privacy, your bank or credit card statements will only show the name of our parent company, not the product.
For your security, we will never call you and ask for your credit card number, or personal information.
See more details about Gene-Eden-VIR/Novirin in Package Insert.
Call us and ask about promotions
The Center for the Biology of Chronic
Disease (CBCD) has just learned that Doctor and television personality Dr. Oz,
recently dropped by HuffPost Live, to discuss the Gardasil HPV vaccine.
During the interview, Dr. OZ made the case
that because Gardasil's efficacy wears off after five years, it might make
sense to delay vaccination until a boy or girl is fourteen years old or older.
"My sense after having done the show, is
that I don't feel that urge to push for an 11 or 12 year old kid to have the
vaccine ... normally I would've been much more supportive of an 11 year old child
getting the vaccine, until I heard from Dr. Harper that it wears off after 5
to 6 years. So, since the peak time of intercourse is a little bit later,
maybe you want to stall the decision about a vaccine until, let's say, 14
years of age." - Dr. OZ
Although the CBCD understands that many
parents are concerned that being vaccinated against an HPV infection is
important and should be done as soon as possible, the Center agrees with Dr.
The CBCD highlights the fact that there are
other, more serious concerns parents should be worrying about when it comes to
For instance, the CBCD simply does not
believe that the available science backs up the efficacy claims made by Merck
& Co., Inc., the FDA, or the CDC.
The HPV Vaccine is clearly the least
effective method of protection when trying to guard the public against the
virus that can cause some forms of cancer as well as genital warts ... despite the
claims made by the organizations mentioned above.
Merck & Co., Inc., the pharmaceutical
giant, made Gardasil which is intended to help stop four strains of HPV - two
responsible for cervical cancer and two that cause genital warts - while
Cervarix, made by GSK, aims at only two strains.
The trouble the CBCD sees is that these HPV
vaccines are extremely limited in the protection they claim to provide, yet
there are 150 other types of HPVs, at least 15 of which can cause cancer, and
neither Gardasil nor Cervarix provide protection against these other strains.
What's more, Merck's own studies
demonstrate that the vaccine is only effective for 5 years. Thus, if your 11
year old daughter gets the vaccine, it will have stopped working by the time
she is 16 ... right when she is actually at the highest danger of acquiring an HPV
Finally, the HPV vaccine doesn't do a thing
for those who have an HPV infection already. It won't get rid of genital
warts, and if someone is already experiencing abnormal cervical cells due to
HPV ... the vaccine simply does zilch for that person.
There are no approved treatments that
actually kill the virus, and the CBCD finds this is striking.
Thus, a healthy immune system is a person's
best defense against HPV caused diseases.
The good news is that the U.S.'s CDC says,
"In 90% of cases, the body's immune system clears HPV naturally within two
However, clearing the virus does not mean
the virus leaves the body for good. It just means that your immune system is
potent enough to prevent the virus from causing a disease. The virus itself
recognizes this and establishes itself in one of the body's organs in what
scientists call a latent infection. When a virus is latent, it acts as if it
is asleep. Non-scientists would say that it is dormant. A weakened immune
system, however, allows the HPV virus to "wake up" and become active again.
That's why the CBCD would like to point out
an HPV remedy that boosts the immune system and helps target the latent HPV
virus that causes genital warts and some kinds of cancer.
"The key to your health is to reduce the
level of the chronic viruses in your body to harmless levels." - Dr. Hanan
The name of that HPV remedy is
Gene-Eden-VIR. This all natural, scientifically designed product helps your
own body maintain low concentrations of the latent, (sleeping) Human
You may have questions about the efficacy,
safety, and cost of Gene-Eden-VIR. These are great, easily answered questions.
Gene-Eden-VIR is highly effective against
the latent Human Papillomavirus; each ingredient was chosen through a
scientific approach. PolyDNA scientists scanned thousands of scientific and
medical papers published in various medical and scientific journals around the
world in order to identify the safest, most effective natural ingredients that
target the latent (sleeping) HPV Virus.
Gene-Eden-VIR is safe. There are
no reports of side effects, and it has been on the market for over three
years. Each capsule contains a patented formula of five all natural
ingredients including selenium, camellia sinesis extract, quercetin,
cinnamomum extract, and licorice extract. In addition, each bottle is GMP
People can access these scientific
papers on the ingredients of Gene-Eden-VIR on
Gene-Eden-VIR is sold online through the
Gene-Eden website. Each bottle of Gene-Eden-VIR (a one
month's supply) costs $42.99.
Moreover, ordering Gene-Eden-VIR is
secure and confidential.
To learn more about Gene-Eden-VIR, the only
product on the market today that helps the body maintain low numbers of the
latent Human Papillomavirus (HPV) and that is scientifically backed by
published material, visit Gene-Eden-VIR website
or, call polyDNA's American line at: 585-250-9999.
 Human Papillomaviruses and Cancer,
National Cancer Institute, September 7, 2011,http://www.cancer.gov/cancertopics/factsheet/Risk/HPV/print
 Haug CJ, Human Papillomavirus
Vaccination - Reasons for Caution, New England Journal of Medicine, August 21,
2008, 359; 861-862.
 Tomljenovic L and Shaw CA, Human
Papillomavirus (HPV) Vaccine Policy and Evidence-Based Medicine: Are They at
Odds? Annals of Medicine December 22, 2011;
Note: This press release was first issued by The Center for the
Biology of Chronic Disease (CBCD), a not-for-profit organization that specializes
in researching the biology of foreign DNA.